Differentiated thyroid cancer*
A LOOK AT THE TREATMENT JOURNEY
*papillary or follicular thyroid cancer (2 types of differentiated thyroid cancer) that has progressed on a VEGFR-targeted/tyrosine kinase inhibitor medicine and radioactive iodine is not an option.
If you are being treated for papillary or follicular thyroid cancer — 2 types of differentiated thyroid cancer — you may be wondering “what’s next”?
Everyone's journey is unique. Learning as much as you can about your condition will help you make decisions about your future.
Understanding next steps
It’s Your Journey
The information here may help you learn about your options, whether you are taking your initial — first-line — VEGFR-targeted/tyrosine kinase inhibitor (TKI) medicine or considering your next — second-line — TKI medicine.
Knowing your options will help you have an informed conversation with your doctor, who is your best resource for discussing your treatment or condition. Together, you will be able to choose what medicine is right for your situation.
How you may move forward depends on where you are in your journey.
Click on the tab below that best describes your situation.
Sometimes a first-line TKI medicine isn't appropriate anymore. Maybe your condition is progressing or you need another treatment option. If you can’t receive radioactive iodine (RAI), your doctor may discuss using a different TKI medicine. You do have choices. Learn about your options so you can actively participate in your care.
Understanding your options may help you get the treatment that's right for your situation. You can use what you learned from your treatment experience to advocate for yourself by asking your doctor specific questions and expressing your preferences and concerns.
Understand Your Options if Your Condition Progresses
Hear from Cory Lee, an actual patient, why it's important to learn about your treatment options.
Talking to Your Doctor
Get a Doctor Discussion Guide to help make the most of your medical appointments. You can use the guide to organize what you want to talk about regarding your treatment and goals, including:
- What are my treatment options?
- What is CABOMETYX?
- How is CABOMETYX thought to work?
This is a good time to learn more about your condition and treatments. Learning as much as you can allows you to actively participate in your care and may help you feel more in control.
Understanding your options will help you be prepared if your condition progresses or if you need to change your medicine (take a second-line TKI). You will be able to advocate for yourself by asking your doctor specific questions and expressing your preferences and concerns. Though you may not need to change your medicine now, you can be ready if you have to in the future.
The Treatment Journey: Stages and Terms You Should Know
Follow the journey of Cory Lee, an actual patient, and learn about different treatments, terms, and important tips.
Learn about CABOMETYX
What is CABOMETYX?
Though there are other TKIs, CABOMETYX is the only FDA-approved second-line TKI medicine for people with papillary or follicular thyroid cancer (2 types of differentiated thyroid cancer) who have progressed after treatment with a VEGFR-targeted/TKI medicine and can't receive RAI.
Cory Lee's Story
Air Force veteran Cory Lee, an actual patient, shares his story. Track his journey from diagnosis to how he worked through the tough times with his family and support network.
SUPPORT AND ADVOCACY GROUPS